# Double-Blind Clinical Trial of Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease

> **NCT06008717** · NA · NOT_YET_RECRUITING · sponsor: **Mallory Hacker** · enrollment: 40 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** active subthalamic nucleus deep brain stimulation plus optimal drug therapy
- **DEVICE:** inactive subthalamic nucleus deep brain stimulation plus optimal drug therapy

## Key facts

- **NCT ID:** NCT06008717
- **Lead sponsor:** Mallory Hacker
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2028-01-01
- **Primary completion:** 2032-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06008717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06008717, "Double-Blind Clinical Trial of Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06008717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*